Journey Medical Corporation to Present at Conference
Journey Medical Corporation, a leading pharmaceutical company that specializes in dermatological treatments, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. Known by its ticker symbol (Nasdaq: DERM), the company primarily focuses on FDA-approved prescription products designed to treat various skin conditions. Claude Maraoui, the President and CEO, will present a corporate overview that showcases the company’s accomplishments and future objectives.
Corporate Overview Presentation Details
The presentation is scheduled to begin on September 9, 2024, at 7:00 a.m. ET, and will be available for on-demand viewing by conference attendees. This provides an excellent opportunity for potential investors and stakeholders to gain valuable insights into Journey Medical’s operations and strategic direction. Additionally, the company will engage in one-on-one meetings during the conference to connect directly with interested parties.
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) is well-regarded for its effective sales and marketing strategies within the dermatology sector. The company boasts a strong portfolio that includes seven branded and two generic prescription products, playing a vital role in the treatment and management of various skin conditions. The team at Journey Medical consists of seasoned professionals who have significantly contributed to the development of some of the most recognized dermatological brands available today.
Company History and Foundations
Founded by Fortress Biotech, Inc. (Nasdaq: FBIO), Journey Medical has built a strong foundation in the pharmaceutical industry. Based in Scottsdale, Arizona, the company is dedicated to innovation and improving patient outcomes through its competitive product offerings.
Continuous Growth and Development
Journey Medical is committed to ongoing growth within the dermatology sector. With continuous efforts in research and development, along with a strategic focus on marketing and sales, the company aims to broaden its product range and reach a wider patient demographic. Their dedication to addressing complex dermatological needs is evident in their various initiatives.
Contact Information
For more information, Journey Medical Corporation encourages inquiries through their corporate contacts. Jaclyn Jaffe can be reached at (781) 652-4500 for investor relations, while media inquiries should be directed to Tony Plohoros at 6 Degrees at (908) 591-2839.
Frequently Asked Questions
What is the main focus of Journey Medical Corporation?
Journey Medical specializes in selling FDA-approved prescription products for dermatological conditions.
Who will be presenting at the H.C. Wainwright conference?
Claude Maraoui, the President and CEO of Journey Medical, will deliver the presentation.
When can attendees access the presentation?
Conference attendees will be able to view the presentation on-demand starting September 9, 2024.
How many products does Journey Medical market?
The company markets seven branded and two generic products related to dermatology.
Where is Journey Medical Corporation based?
Journey Medical is headquartered in Scottsdale, Arizona.